Opportunity to benefit over 2 million patients annually

The Eximis Surgical platform has the potential for use in multiple minimally invasive procedures, including hysterectomies which are performed over a million times annually.

market potential chart

A $2 billion market potential

With the huge number of procedures performed and the clinical value that Eximis Surgical may provide, the untapped market of minimally invasive specimen removal can grow to be $2B over the next five years.

2.2M Worldwide Annual Procedures